Literature DB >> 18502071

Acute epiglottitis in Iceland 1983-2005.

Birgir Briem1, Ornolfur Thorvardsson, Hannes Petersen.   

Abstract

OBJECTIVE: To describe the changes in the epidemiology of epiglottitis in Iceland from 1983 to 2005.
METHODS: All patients with the discharge diagnosis of epiglottitis during the study years were identified and diagnosis confirmed by chart review. Main outcome measures were age, gender, month/year of diagnosis, microbiology, airway management, ICU admissions, choice of antibiotics, length of hospital stay and major complications/mortality.
RESULTS: Fifty-seven patients were identified (annual incidence 0.93/100.000). The mean age was 33.3 years (1-82). Childhood epiglottitis disappeared after introduction of Haemophilus influenzae type b (Hib) vaccination in 1989 but adult disease showed non-significant increase. In the pre-vaccination era Hib was the most common organism cultured but it has not been diagnosed in Iceland since 1991 and Streptococci are now the leading cause of epiglottitis. The mean hospital stay was 5.05 nights with 51% of patients admitted to ICU. All children under 10 years and a total 30% of patients received airway intervention. Ninety percent of adults were observed without airway intervention. Major complications were rare and mortality was 0% in our series.
CONCLUSION: There have been major changes in the epidemiology of epiglottitis in Iceland during the study period. Previously a childhood disease, epiglottitis has disappeared in children and is now almost exclusively found in adults. This can be attributed to widespread Hib vaccination, eliminating the major causative agent in children. The treatment of this life-threatening disease remains a challenge. Our series suggest that it is safe to observe patients with mild/moderate symptoms without airway intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502071     DOI: 10.1016/j.anl.2008.03.012

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  8 in total

1.  Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus.

Authors:  Sirirat Charuvanij; Kristin M Houghton
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-31       Impact factor: 3.054

2.  Adult supraglottitis: changing trends.

Authors:  Sharon Ovnat Tamir; Tal Marom; Irina Barbalat; Stanislav Spevak; Abraham Goldfarb; Yehudah Roth
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-21       Impact factor: 2.503

3.  Rapid assessment of Hib disease burden in Vietnam.

Authors:  Batmunkh Nyambat; Duc Anh Dang; Hien Anh Nguyen; Trinh Quynh Mai; Manju Rani; Mary P E Slack; Paul E Kilgore
Journal:  BMC Public Health       Date:  2011-04-25       Impact factor: 3.295

4.  Unexpected custodial death due to acute epiglottitis: A rare autopsy case report.

Authors:  Shifan Wu; Luo Zhuo; Xingang Qiu; Zijiao Ding; Mingzhen Yang; Meichen Pan; Qian Liu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Risk of acute epiglottitis in patients with preexisting diabetes mellitus: A population-based case-control study.

Authors:  Yao-Te Tsai; Ethan I Huang; Geng-He Chang; Ming-Shao Tsai; Cheng-Ming Hsu; Yao-Hsu Yang; Meng-Hung Lin; Chia-Yen Liu; Hsueh-Yu Li
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

6.  Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant.

Authors:  Jumpei Fujisawa; Tomokazu Mutoh; Kengo Kawamura; Nami Sawada; Daisuke Ono; Tetsuo Yamaguchi; Ichiro Morioka
Journal:  Infect Drug Resist       Date:  2018-10-31       Impact factor: 4.003

7.  Infectious and Noninfectious Causes of Epiglottitis in Adults, Review of 24 Patients.

Authors:  İsrafil Orhan; Salih Aydın; Turgut Karlıdağ
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-03-01

8.  End-stage renal disease as a risk factor for epiglottitis: a population-based cohort study in Taiwan.

Authors:  Yao-Te Tsai; Ming-Shao Tsai; Cheng-Ming Hsu; Ku-Hao Fang; Ethan I Huang; Chia-Yen Liu; Meng-Hung Lin; Yao-Hsu Yang; Yi-Chan Lee; Geng-He Chang
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.